Astra’s Tabuk Pharmaceuticals to commercialize Moderna COVID-19 vaccine in Saudi Arabia

12/06/2021 Argaam

Tabuk Pharmaceutical Manufacturing headquarters

Tabuk Pharmaceutical Manufacturing Co., a fully owned subsidiary of Astra Industrial Group, signed an agreement with Nasdaq-listed Moderna, to commercialize the Moderna COVID-19 vaccine and future variant-specific booster candidates in Saudi Arabia, according to a press release issued by Moderna on June 11.

 

Tabuk Pharmaceutical Manufacturing was established in 1994, to produce, market and distribute various pharmaceutical products, according to data compiled by Argaam.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.